Patient

Clinical Information

In the 70 years before the second half of 2020, China had only 15 ALS drug clinical pipelines, which means that there was only one ALS drug clinical pipeline every five years. However, through the efforts of Cai Lei and his team, as well as the joint support of all sectors of society, China has launched more than 30 clinical pipelines since the second half of 2020. Till 2024, we have cooperated to promote more than 20 clinical pipelines of ALS drug research and development, greatly increasing the speed of drug research and development.

These pipelines are rapidly progressed through clinical stages following ethical considerations, animal experiments, and safety validations. They are then swiftly launched on the "Askhelpu" data platform, enabling rapid recruitment on an hourly basis and precise matching of patients.